The use of tissue microarrays in oncology: from research to diagnostic application

 

Authors

  • R. Franco Pathology Unit, Istituto Nazionale Tumori IRCCS – “Fondazione G. Pascale”, Napoli, Italy.
  • G. Scognamiglio Pathology Unit, Istituto Nazionale Tumori IRCCS – “Fondazione G. Pascale”, Napoli, Italy.

Keywords:

diagnosis, oncology, tissue microarrays

Abstract

Tissue microarray (TMA) technology has been widely developed and utilized in recent years for all tissue-based oncology research, mainly to identify prognostic and predictive biomarkers in cancer research. Recently the use of TMA has been implemented in the clinical setting, in order to provide cancer-specific molecular data needed to define the correct therapeutic strategy. In this context, the definition of the receptor status of breast cancer seems to be the best example of application in clinical pathology laboratories. In this review, we analyze the fields of application of TMA technology in oncology.

Downloads

Published

2013-10-15

How to Cite

1.
Franco R, Scognamiglio G. The use of tissue microarrays in oncology: from research to diagnostic application:  . CBN [Internet]. 2013 Oct. 15 [cited 2024 Dec. 4];1(1):29-32. Available from: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/253

Issue

Vol. 1 No. 1 (2013): January - December 2013

Section

Breaking from the Lab

License

Articles published in Cancer Breaking News are distributed under the CC Attribution-NonCommercial-NoDerivatives 4.0 license, which allows third parties to copy and redistribute the material providing appropriate credit and a link to the license but does not allow to use the material for commercial purposes and to use the material if it has been remixed, transformed or built upon.